XML 78 R45.htm IDEA: XBRL DOCUMENT v3.19.3
Collaborative Arrangements and Acquisitions - Exonics Therapeutics (Details) - USD ($)
$ in Thousands
9 Months Ended
Jul. 16, 2019
Sep. 30, 2019
Dec. 31, 2018
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Fair value of contingent development and regulatory payments   $ 172,041  
Goodwill   $ 447,525 $ 50,384
Exonics Therapeutics      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Upfront payment (adjusted for customary working capital adjustments) $ 266,315    
Fair value of contingent development and regulatory payments 172,041    
Total purchase price 438,356    
Cash and cash equivalents 19,535    
Goodwill 397,141    
Intangible asset 13,000    
Net other assets (liabilities) 8,680    
Goodwill, and liabilities assumed, net $ 438,356